Previously, we have demonstrated that a DNA helicase-like protein, termed RTEL (regulator of telomere length) is essential for the maintenance of genomic stability. RTEL deficiency induced telomere loss and genomic instability, leading to embryonic lethality. However, the role of RTEL in these biological pathways is largely unknown. To uncover RTEL’s function(s), we applied several approaches to identify the proteins that could interact with RTEL. Proliferating Cell Nuclear Antigen (PCNA), the key regulator of the replication fork, was found to be a strong candidate. In this study, we have demonstrated the interaction between RTEL and PCNA. Further characterization of the interaction between RTEL and PCNA revealed that the interaction is important for maintaining genomic stability. Due to the essential role of PCNA in nucleic acid metabolism as a component of the replication and repair machinery, its interaction with RTEL could be the key to the role of RTEL in the maintenance of genomic stability and mouse development. Along with a bioinformatics approach, we have employed several biochemical approaches to identify the interaction of PCNA with RTEL. Using co-immunoprecipitation, we have demonstrated that RTEL can specifically interact with PCNA. A PCR-based mutagenesis method was used to mutate the PCNA-interacting motif (PIP) in RTEL. Further we have demonstrated that several key amino acids in the PIP motif are responsible for mediating RTEL/PCNA interaction by using co-immunoprecipitation and immunofluorescence studies. Using a gene-targeting approach, we have specifically knocked-in a mutant RTEL with a mutation in PIP motif into mouse genome. Thus we have developed a transgenic mouse model to study the significance of the interaction between RTEL/PCNA in vivo. This study not only validated the interaction of RTEL with PCNA, via the PIP box, but also generated the RTEL PIP mutant alleles for further functional analysis by transgenic approaches. We have employed biochemical and cytogenetic studies to characterize the phenotypes in RtelI1169A/I1169A mouse. This is the first direct genetic approach to address whether PCNA is an important downstream mediator of RTEL’s function in the regulation of genomic integrity

Previously, we have demonstrated that a DNA helicase-like protein, termed RTEL (regulator of telomere length) is essential for the maintenance of genomic stability. RTEL deficiency induced telomere loss and genomic instability, leading to embryonic lethality. However, the role of RTEL in these biological pathways is largely unknown. To uncover RTEL’s function(s), we applied several approaches to identify the proteins that could interact with RTEL. Proliferating Cell Nuclear Antigen (PCNA), the key regulator of the replication fork, was found to be a strong candidate. In this study, we have demonstrated the interaction between RTEL and PCNA. Further characterization of the interaction between RTEL and PCNA revealed that the interaction is important for maintaining genomic stability. Due to the essential role of PCNA in nucleic acid metabolism as a component of the replication and repair machinery, its interaction with RTEL could be the key to the role of RTEL in the maintenance of genomic stability and mouse development. Along with a bioinformatics approach, we have employed several biochemical approaches to identify the interaction of PCNA with RTEL. Using co-immunoprecipitation, we have demonstrated that RTEL can specifically interact with PCNA. A PCR-based mutagenesis method was used to mutate the PCNA-interacting motif (PIP) in RTEL. Further we have demonstrated that several key amino acids in the PIP motif are responsible for mediating RTEL/PCNA interaction by using co-immunoprecipitation and immunofluorescence studies. Using a gene-targeting approach, we have specifically knocked-in a mutant RTEL with a mutation in PIP motif into mouse genome. Thus we have developed a transgenic mouse model to study the significance of the interaction between RTEL/PCNA in vivo. This study not only validated the interaction of RTEL with PCNA, via the PIP box, but also generated the RTEL PIP mutant alleles for further functional analysis by transgenic approaches. We have employed biochemical and cytogenetic studies to characterize the phenotypes in RtelI1169A/I1169A mouse. This is the first direct genetic approach to address whether PCNA is an important downstream mediator of RTEL’s function in the regulation of genomic integrity

La dystrophine est une protéine cytoplasmique qui lie physiquement le cytosquelette à la matrice extracellulaire par le biais du complexe dystrophine-protéines associées (DAPC), assurant ainsi la stabilité du sarcolemme. Des mutations dans le gène DMD codant pour la dystrophine, conduisant à l’absence de la protéine, sont à l’origine de la dystrophie musculaire de Duchenne qui est une maladie liée au chromosome X. Pour mes travaux de thèse, j’ai généré et caractérisé un nouveau modèle de souris transgéniques rapportrices, dénommé DmdEGFP, qui exprime une protéine dystrophine endogène fusionnée avec la protéine fluorescente EGFP. La protéine dystrophine est liée dans sa région C-terminale qui est présente dans la majorité des isoformes. Dans le modèle, une expression forte et naturelle de l’EGFP était observée dans les muscles squelettiques, lisses, le cœur, le cerveau et l’œil, ce qui suggère un étiquetage correct de tous les isoformes de la dystrophine. La fluorescence de l’EGFP co-localisait exactement avec la dystrophine dans tous les sites. Dans le muscle squelettique, la dystrophine ainsi que d’autres protéines de la DAPC étaient exprimées dans des quantités normales et dans la bonne localisation subsarcolemmale. L’architecture du tissu musculaire squelettique était normale, suggérant que la fonction de la protéine de fusion était maintenue. In vitro, l’EGFP est également exprimée dans les fibres musculaires isolées, ainsi que dans les myotubes dérivés des cellules satellites. Par conséquent, cette nouvelle souris rapportrice de la dystrophine devient un outil important pour la visualisation directe et in vivo de l’expression de la dystrophine. / Dystrophin is a rod-shaped cytoplasmic protein that physically links the cytoskeleton to the ECM through the dystrophin-associated protein complex (DAPC), thereby providing sarcolemmal stability. Mutations in the dystrophin encoding DMD gene cause the severe X-linked disorder Duchenne muscular dystrophy. In this work a novel DmdEGFP reporter mouse that expresses a fluorescently labelled endogenous dystrophin – EGFP fusion protein was generated and characterized. The protein was tagged at the C-terminus that is present in the most dystrophin isoforms. To date, no dystrophin reporter mice exist, thus imaging is only possible by indirect antibody-mediated processing ex vivo. In DmdEGFP mice strong natural EGFP expression was observed in skeletal, smooth muscles, heart, brain and the eye and EGFP fluorescence co-localized with dystrophin at all sites suggesting proper tagging of the major dystrophin isoforms. In skeletal muscle, dystrophin as well as other proteins of the DAPC were expressed in normal quantity at correct sarcolemmal/subsarcolemmal localization. Skeletal muscle maintained normal tissue architecture, suggesting a correct function of the fusion protein. Isolated myofibers as well as satellite-cell derived myotubes expressed EGFP in vitro. Thus, the novel dystrophin reporter mouse provides a valuable tool for direct visualization of dystrophin expression.

Diabetic nephropathy (DN) remains the most common cause of end stage renal failure. Nearly 10% of patients with diabetes develop nephropathy. Hyperglycaemia in the kidneys leads to the activation of alternative metabolic pathways of glucose (glycation, activation of protein kinase C, and polyol pathway). These biochemical alterations lead to hypoxia and oxidative stress due to the increased formation of reactive oxygen species (ROS). Cellular response to hypoxia is controlled by hypoxia-induced factor 1 (HIF1), which is involved in the regulation of more than 800 genes. Target molecules of the HIF1 pathway participate in a wide range of physiological and pathological processes, e.g. angiogenesis, energy metabolism, apoptosis, migration, and proliferation. DN is associated with the pathological tissue remodelling process, epithelial-mesenchymal transition (EMT), and inflammation. HIF1 regulates key molecules of these pathological processes. EMT is regulated by TGFß1, CTGF, and SOX9. The progression of inflammation is regulated by VEGFA and AngII. The exact role of HIF1 signalling in the development of DN is not yet fully understood. This thesis evaluates the functional role of the HIF1 signalling pathway in the development of DN using a global heterozygous mutant with the deletion of the Hif1α gene....

No description available.

Les corticosurrénalomes (CS), bien que rares, sont des tumeurs malignes du cortex surrénalien très agressives. Environ 30% des patients atteints de cancer surrénalien présentent des métastases au diagnostic et leur survie à 5 ans est inférieure à 20%. Les mécanismes à l’origine de la progression cancéreuse ne sont pas complètement élucidés. Leur compréhension est pourtant un préalable à la mise au point de traitements adaptés. Les mutations du gène P53 font parties des altérations génétiques les plus fréquentes dans les CS. Dans ce contexte, il est légitime d'étudier l'effet de l'inactivation de P53 spécifiquement dans les surrénales de souris. L'antigène T du virus SV40 est un oncogène qui se lie et inhibe P53 et RB. Le laboratoire dispose de souris transgéniques (modèle AdTAg) exprimant l’antigène T de SV40 dans le cortex surrénal qui développent des tumeursévolutives. L’objectif de ce travail était de caractériser l’ontogenèse de ces tumeurs et d’explorer les modifications cellulaires et moléculaires qui accompagnent leur progression maligne notamment en lien avec les signalisations β-caténine et IGF2/mTOR. Les souris AdTAg développent des tumeurs surrénaliennes récapitulant l’ensemble des caractéristiques décrites pour les CS humains. En effet, elles présentent une surmortalité à partir de 22 semaines associée à la survenue de métastases pulmonaires et hépatiques. Les tumeurs sont à l'origine d'une hypercorticostéronémie témoignant de leur différenciation stéroïdogénique. L'analyse du score de Weiss à différents stades montre une évolution de la bénignité vers la malignité. Cette progression tumorale s’accompagne d’une activation précoce de la voie mTOR et tardive de la voie Wnt/β-caténine. Ces deux voies de signalisation pourraient donc constituer des cibles thérapeutiques intéressantes. La deuxième partie du projet visait à utiliser ce modèle murin pour tester une thérapie anticancéreuse applicable au carcinome surrénalien. La rapamycine, un inhibiteur de mTOR, inhibe la prolifération cellulaire et induit une apoptose des cellules tumorales. Après 3 mois de traitement, une réduction significative du volume tumoral est constatée ainsi que la normalisation des taux de corticostérone. Nous avons également évalué l'effet antitumoral d'inhibiteurs de la voie Wnt/β-caténine: la quercetine et le PRI-724. La quercetine stoppe la progression tumorale en inhibant la prolifération cellulaire. Elle prolonge significativement la survie des souris AdTAg. Cependant, nous n'avons pas de preuve moléculaire d'inhibition de la voie Wnt/β-caténine dans les surrénales AdTAg et les mécanismes d'action de la molécule restent à élucider. A l'inverse, le PRI-724 semble être un inhibiteur spécifique de la voieWnt/β-caténine capable de bloquer l'interaction CBP/β-caténine. Un traitement de 2 mois permet une réduction significative du volume tumoral chez les souris AdTAg. La baisse d'expression de certains gènes cibles de l'interaction CBP/β-caténine témoigne d'une inhibition de la voie. Les résultats obtenus avec les inhibiteurs des voies mTOR et Wnt/β-caténine dans le modèle murin de CS sont prometteurs. L'utilisation de ces molécules pourrait donc être envisagée dans le traitement du CS. / Adrenocortical carcinoma (ACC) is a rare aggressive malignant tumor of adrenal cortex. 30% of patients have metastatic disease at diagnosis and the 5 year-survival rate is obtained inonly 20%. Unfortunately, the mechanisms of tumorigenesis are not well identified. Understanding these mechanisms could offer perspectives for new targeted therapies improving the survival in these patients. P53 inactivation in the adrenal cortex seems a good target to study its role in the tumorigenesis. Large T antigen of SV40 virus is an oncogene that fixes and inhibits P53 and RB. Our laboratory has mouse models expressing this antigen (AdTAg mouse model) in the adrenal cortex and developping progressive adrenal tumors. The initial objective was to characterize the ontogeny of these tumors, studying their molecular characteristics, especially β-catenin and IGF2/mTOR signaling, during the malignant progression. AdTAg mouse models develop adrenocortical tumors with characteristics that are identical to human ACC. They present pulmonary and liver metastases that lead to increased mortality rate from 22 weeks old. These tumors lead to hypercorticism that suggest their steroidogenic differentiation. Weiss score analyses indifferent ages show that these tumors progress from benign to malignant ones, associated with a precocious activation of mTOR pathway and tardive activation of Wnt/β-catenin pathway. These pathways are thus interesting therapeutic targets. The second part of this thesis was concentrated on the anti-cancer treatment trials. Rapamycin, an mTOR inhibitor inhibits cell proliferation and increases cell apoptosis in these tumors. After 3 months of treatment, the tumor burden was significantly reduced and corticosterone levels were normalized. We have also evaluated effects of Wnt/ β-catenininhibitors, Quercetin and PRI-742, in our mouse models. Quercetin inhibits tumor proliferation and progression and it extends the survival rate of AdTAg mice. Surprisingly, this effect was independent of Wnt/β-catenin activity and the molecular mechanisms remain to be elucidated. Inversely, PRI-724 seems to be a specific inhibitor of this pathway, blocking the interaction between CBP and β-catenin. A treatment of 2 months reduced significantly the tumor volume in AdTAg mice. This effect was through the inhibition of CBP and β-catenininteraction and signaling. These results encourage using the inhibitors of mTOR and Wnt/β-catenin pathway offering promising targets to improve the survival in patients with ACC.

No description available.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

Loss of hearing affects more than 10 % of the population, and one newborn in a thousand is born with defects of the inner ear. Transcriptional factors involved in the development of inner ear are important in our understanding of the causes of inner ear defects. ISLET1 is one of these factors. ISLET1 expression is detected in the sensory and neuronal cells of the inner ear. It participates in otocyst formation, and the specification and differentiation of cells of cochlea and vestibular system. The functional role of ISLET1 during inner ear development was investigated. Its role was studied by using Pax2-Isl1 transgenic mice that overexpress Islet1 under the control of the Pax2 promoter. Two transgenic lines were generated, Pax2-Isl1/300 and Pax2- Isl1/52. Two copies of the Pax2-Isl1 transgene were inserted to Pax2-Isl1/300 genome and one copy was inserted to the Pax2-Isl1/52 genome. Defects in sense of hearing were detected in both lines and circling behavior, a defect of balance, was detected in the Pax2-Isl1/300 transgenic mice. We observed high postnatal lethality in heterozygote transgenic mice. Pax2-Isl1/52 homozygote mutation is lethal at embryonic day 10 (E10,5). Pax2-Isl1/300 homozygote letality couldn't be detected because of the inability to breed heterozygote mutated mice of this line....